Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Will Moderna's mRESVIA Impact Younger Adults?
Management & Regulatory How Will Moderna's mRESVIA Impact Younger Adults?

As temperatures cool and the common cold season descends, a significant health risk may be lurking unnoticed for many younger adults. Respiratory Syncytial Virus (RSV), once considered a pediatric and elderly threat, has raised concerns for adults aged 18 to 59 with underlying health conditions.

Can a Single Dose of PGE2 Reverse Muscle Aging?
Biotech & Bioprocessing Can a Single Dose of PGE2 Reverse Muscle Aging?

In recent years, the aging global population has brought significant attention to age-related health issues, especially sarcopenia—a condition marked by the loss of muscle mass and function. As traditional approaches such as exercise and nutrition struggle to counteract the cellular dysfunctions

NICE Endorses GSK's Blenrep Combo for Multiple Myeloma
Management & Regulatory NICE Endorses GSK's Blenrep Combo for Multiple Myeloma

Multiple myeloma remains a formidable challenge in oncology, known for its relentless cycle of relapse and treatment resistance. This blood cancer, which originates in plasma cells within the bone marrow, continues to affect patients profoundly, with around 6,240 individuals diagnosed annually in

How Is Process Intensification Transforming Biopharmaceuticals?
Biotech & Bioprocessing How Is Process Intensification Transforming Biopharmaceuticals?

The biopharmaceutical industry finds itself at a crossroads as the ever-increasing global demand for pharmaceuticals necessitates a reevaluation of traditional manufacturing approaches. With escalating costs and inefficiencies hindering timely drug production, the sector is turning towards a

U.S. States Lead Charge on Genetic Privacy Laws in 2025
Management & Regulatory U.S. States Lead Charge on Genetic Privacy Laws in 2025

The realm of genetic privacy has garnered profound attention from lawmakers in the United States as they confront unfolding challenges related to genetic information security and confidentiality. This year, legislative bodies have demonstrated a proactive stance on addressing pressing issues

Genomic Study Advances Equity in Prostate Cancer Treatment
Research & Development Genomic Study Advances Equity in Prostate Cancer Treatment

Imagine facing a life-threatening illness only to find that your race determines the quality of treatment you receive. This scenario, unthinkable to many, is a stark reality for individuals battling metastatic prostate cancer. However, recent groundbreaking research offers new avenues to overcome

University of Michigan Tightens Policies After Smuggling Arrests
Biotech & Bioprocessing University of Michigan Tightens Policies After Smuggling Arrests

The University of Michigan finds itself in the spotlight as it reviews its internal policies in response to alarming incidents involving biohazardous materials. Recently, two Chinese nationals affiliated with the institution were arrested for attempting to smuggle these materials into the United

AI Revolutionizes Drug Development with NVIDIA and IQVIA Partnership
Management & Regulatory AI Revolutionizes Drug Development with NVIDIA and IQVIA Partnership

The pharmaceutical industry, often characterized by lengthy and costly drug development cycles, is on the brink of a revolutionary shift. A strategic partnership between IQVIA, a leader in clinical research services, and NVIDIA, a cutting-edge technology company renowned for AI innovations,

Irish Digital Health: Navigating Telemedicine and EU Regulations
Management & Regulatory Irish Digital Health: Navigating Telemedicine and EU Regulations

In the evolving landscape of digital health, Ireland has positioned itself at the forefront of telemedicine by focusing on integrating innovative healthcare solutions with robust regulatory frameworks. The Irish government's strategic emphasis on digitalization aims to streamline healthcare

Is CASGEVY the Future of Gene Therapy for Sickle Cell?
Biotech & Bioprocessing Is CASGEVY the Future of Gene Therapy for Sickle Cell?

With the development of gene therapies in the treatment of genetic disorders, the recent advances made by CRISPR Therapeutics draw significant attention. The emergence of their flagship therapy, CASGEVY, presents a promising alternative, particularly for sickle cell disease. Sickle cell disease, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later